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Summary
Obesity is prevalent among a third of US adults and a leading indicator for many
chronic diseases. Self-efficacy is important for non-surgical weight loss interventions,
but there is less information about the role of self-efficacy in the candidacy phase
when there are discussions of side effects and decisions for uptake. This study con-
ducted an experiment set within an online survey assessing risk aversion towards
bariatric surgery as a weight loss intervention. The survey asked about hypothetical
weight loss scenarios for bariatric surgery among a national probability-based sample
of US adults aged 18 years and older. Participants answered their willingness to
achieve different weight loss amounts within the context of bariatric surgery in vary-
ing risk scenarios. The analysis utilized a repeated-measures linear mixed model. A
three-way interaction demonstrated that participants were more willing to take risks
under ideal weight loss conditions even with the risk of death, particularly when con-
sidering self-efficacy (β = 1.20, P = .05). Margin projections showed that those with
lower self-efficacy were more likely to take risks overall. This trend was significant
for those with a body mass index of 30 and above in scenarios presenting one's ideal
weight as the outcome of bariatric surgery. Adding a measure of self-efficacy within
patient assessments could identify those eligible patients who are most likely to
adopt bariatric surgery, particularly among those who may have negative post-
surgical outcomes due to low self-efficacy levels. Addressing self-efficacy by way of
providing support resources in tandem with candidacy consultations may enhance
quality of life and post-surgical outcomes.
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1 | INTRODUCTION
One third of adults in the United States have obesity, a leading indica-
tor for several chronic diseases, including certain cancers, heart dis-
ease, hypertension and type II diabetes.1 Obesity is also correlated
with depression and lower quality of life,2 and the medical costs asso-
ciated with obesity are estimated at $147 billion annually.3 Although
small reductions in body weight (ie, 5%-7%) can vastly improve the
health of individuals who have obesity, individuals rarely value modest
weight loss.4,5 Moreover, bariatric surgery may be the most effective
intervention for losing large amounts of weight, but this intervention
has low uptake.6,7 According to the National Institutes of Health, peo-
ple with a body mass index (BMI) equal to or greater than 40, or a
BMI of 35-39.9 with an existing comorbidity, are eligible for weight
loss surgery.8 Yet only 1% of those eligible typically uptake a surgical
option to lose weight. One plausible explanation is that individuals
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have an aversion to the risks surgery presents. Primarily, bariatric sur-
gery comes with potential risks of chronic diarrhoea, severe infection
and death.9
Risk aversion has been shown to influence decision-making among
patients when presented with weight loss scenarios.4 Bariatric surgery
patients reported that they expected to lose 38% of their total body
weight on average and would be disappointed if they did not lose at least
24% of their body weight.5 This current research indicates that people
with obesity appear to be more accepting of incurring a small risk of
death to achieve their “dream” weight than to lose clinically meaningful
proportions that can have substantial health benefits (eg, 20% or 10% of
their current weight).4,5 Importantly, extant studies did not experimentally
differentiate other forms of risk based on type or severity. Thus, it is
unclear whether these results were driven by the magnitude of the risk
(eg, death). It is critical to examine risk aversion experimentally and exam-
ine causal antecedents. Although surgical options for obesity are associ-
ated with risks, there are risks simply in having obesity. When presented
with treatment options, outcomes including modest weight loss reduc-
tions may not provide enough incentive to proceed.10
It is unclear how the role of individual attributes may impact risk
aversion in this area. When risks are not observable or known, and
when individuals lack control, this can result in fear and/or anxiety.11
Control or confidence, commonly referred to as self-efficacy, is the
perception that one can engage in behaviour towards a goal despite
perceived barriers.12 Studies show that weight loss self-efficacy is
vital for the success of non-surgical weight loss interventions.13 How-
ever, there is less information about the role of weight loss self-
efficacy in assessing the risk of bariatric surgery. One recent study
showed that eligible patients perceived bariatric surgery as high risk,
but those who were interested were dissatisfied with their current
weight loss results and saw surgery as an opportunity to attain their
goal weight quickly.6
Studying if and how patients' ideal weight or weight loss self-
efficacy might interact with risk-related decision-making for surgical
weight loss interventions is relevant for clinical practice,14 particularly
due to the rise of obesity rates and forecasted projections.15,16 Longi-
tudinal models of patient trajectories have also demonstrated that
individuals with Class I obesity are likely to continue to gain weight
over time.17-19 The purpose of this study was to examine factors that
correlate with the acceptance of risk in relation to bariatric surgery.
This controlled experiment varied risk magnitude and amount of
weight loss expected. The study also assessed weight loss self-
efficacy to see if it moderated the relationship between risk magni-
tude and amount of weight lost in relation to accepting risk.
2 | MATERIALS AND METHODS
2.1 | Study design
The experimental study asked about hypothetical weight loss scenar-
ios for bariatric surgery among a national probability-based sample of
US adults aged 18 years and older. Participants were recruited
through The GfK Group, and the survey was conducted using a
sample from KnowledgePanel in 2013. Eligible individuals were
emailed the online survey and received a cash equivalent of $5 for
their participation. Within the survey, participants were randomly
presented with different experimental conditions that assessed risk
aversion in relation to bariatric surgery. This paper presents a subsam-
ple of participants meeting the criteria for the diagnosis of clinical
obesity (having a BMI greater than or equal to 30) and took part in the
experimental portion. Eligible individuals were presented with all
experimental scenarios. Participants responded about their risk accep-
tance to achieve different weight loss amounts within the context of
bariatric surgery in varying risk scenarios.
2.2 | Measures
At the start of the survey, participants were asked about their current
height and weight, their ideal weight, and demographic variables
including age, gender and race/ethnicity. The primary outcome is risk
“willingness.” Participants were asked to indicate the highest chance
of risk they would be willing to take to lose weight in different scenar-
ios (ranging from 0% risk to 100% risk). Specifically, the survey asked,
WHAT IS ALREADY KNOWN ABOUT THIS
SUBJECT
• Several studies have found that weight loss self-efficacy
is important for the success of non-surgical weight loss
interventions.
• Risk aversion has been shown to influence decision-
making among patients when presented with weight loss
scenarios.
• There is less information about how critical the role of
weight loss self-efficacy is on risk perceptions during the
candidacy phase for bariatric surgery, whereas there are
discussions of varying levels of side effects.
WHAT THIS STUDY ADDS
• Weight loss self-efficacy was a predictor of participants'
willingness to take a high risk in bariatric surgery in the
context of achieving one's ideal weight.
• Those with lower weight loss self-efficacy were more
likely to take a risk overall, but this trend was significant
for those with a body mass index of 30 and above in sce-
narios presenting one's ideal weight as the outcome of
bariatric surgery.
• Adding a measure of weight loss self-efficacy within
patient assessments would identify those eligible patients
who might be most likely to adopt bariatric surgery.
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“Imagine that you could lose weight with the use of weight loss surgery
that involved gastric bypass or banding surgery (sometimes called stom-
ach stapling) and then keep it off with a healthy diet and physical activity.
Please answer the next questions with this type of surgery in mind.”
The outcome of risk willingness was assessed across different sce-
narios, including different weight loss conditions (a: 10% weight loss
or b: percentage for ideal weight loss) within different bariatric sur-
gery side effect levels (a: Low (chronic diarrhoea), b: Moderate (severe
infection), and c: High (death)). For example, in the ideal weight loss
condition and high risk level scenario, the survey asked, “What is the
highest chance of DEATH you would be willing to stake to lose [##]
pounds with stomach surgery?” The symbol [##] was a number, calcu-
lated from each participant's current weight minus their ideal weight
asked at the beginning of the survey and auto-filled into the ideal
weight scenario questions.
A primary variable of interest was weight loss self-efficacy.20 The
weight loss self-efficacy measure was assessed using 12 items
(α = .83). Individuals answered “True” or “False” to general weight loss
self-efficacy items such as “I often doubt whether I have what it takes
to succeed at weight control.” The responses were coded dichoto-
mously, where “False” was coded as one. The items were summed
and centred, where a higher score indicates higher self-efficacy to lose
weight. In addition, there was a question that inquired about minor
comorbidities. The comorbidities available for a portion of the analysis
included pre-diabetes and sleep apnoea. These two comorbidities
were coded as one if endorsed by participants as having been told by
their doctor.
2.3 | Analysis
The analysis was conducted using STATA version 14.2 (StataCorp LP,
College Station, TX). Descriptive statistics were assessed for demo-
graphic variables, weight loss self-efficacy, and participants' willingness
to take risk (by risk level and weight loss condition). We next utilized a
repeated-measures linear mixed model for multivariable analyses.21-25
Two multivariable models were tested for this study. Model 1 was
a constrained model including those individuals with BMIs of 40 and
above, or including those with BMIs of 30 and above with self-
reported pre-diabetes or sleep apnoea. Model 2 expanded the criteria
to those with BMIs of 30 and above. The dependent variable was the
percentage of risk individuals were willing to take (Risk Willingness).
Predictors included the variables, including each condition (Condition)
and risk level (Level) for each individual within each repeated set.
Weight loss self-efficacy was included to assess its potential interac-
tion. Covariates were also added to the models, including BMI, age,
education, gender and race/ethnicity.
After running the two models, margin projections were plotted for
the risk willingness across different levels and conditions by high and
low weight loss self-efficacy. For this step, the original self-efficacy
variable was recoded into a dichotomous variable by splitting
responses at the mean. Those individuals who answered 0% to all sce-
narios were removed for this analysis. Additional analyses were
conducted and found no significant differences in demographics
among the randomization order, as well as those missing.
3 | RESULTS
Table 1 outlines descriptive statistics for the sample of individuals
with a BMI of 30 and above (n = 334). The mean age was 48.3
(SD = 14.3), and the mean BMI was 38.7 (SD = 6.0). A majority of the
sample was Non-Hispanic White (74.6%) and achieved a high school
diploma (31.7%) or some college (33.8%). There were also slightly
more females (56.6%). The average weight loss self-efficacy score was
mid-range at 5.5 (SD = 3.6). In Table 2, the average percentage of risk
a participant was willing to take is shown by the different experimen-
tal conditions. The average percentage decreases as the risk level
increases. However, the average percentage is higher for the ideal
weight loss scenarios (low 18.1%, moderate 12.1%, and high 8.6%)
compared to the 10% weight loss scenarios (low 13.8%, moderate
7.5%, and high 6.5%).
TABLE 1 Descriptive statistics (n = 334)
Mean (SD) or n (%)
Age 48.3 (14.3)
Gender
Male 145 (43.4)
Female 189 (56.6)
Race
Non-Hispanic White 249 (74.6)
Non-Hispanic Black 35 (10.5)
Hispanic 16 (4.8)
Other race/two or more races 34 (10.2)
Education
Less than high school 26 (7.8)
High school 106 (31.7)
Some college 113 (33.8)
Bachelors degree or higher 89 (26.7)
Comorbidity (pre-diabetes or sleep apnoea)
Yes 142 (42.5)
No 180 (53.9)
Body mass index (30 and above) 38.7 (6.0)
Weight loss self-efficacy (0-12 range) 5.5 (3.6)
TABLE 2 Willingness to take risk (by level and condition)
Condition, mean
percentage (SD)
Risk level
10% weight
loss scenario
Ideal weight
loss scenario
Low—chronic diarrhoea 13.8 (23.9) 18.1 (25.5)
Moderate—severe infection 7.5 (17.8) 12.1 (22.1)
High—death 6.5 (18.0) 8.6 (19.1)
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Table 3 outlines the amount of risk a participant in this sample was
willing to take using two repeated-measures linear mixed models. The
models include the different experimental condition and risk level sce-
narios, as well as interactions with weight loss self-efficacy. Model
1 included those with a BMI of 40 and above, as well as those with a
BMI of 30 and above with a comorbidity. Results fromModel 1 indicate
a main effect for taking more risk, on average, with every unit increase
where participants hypothetically achieve their ideal weight (β = 11.5,
P < .01) compared to the 10% weight loss scenario, holding all other
variables constant in the model. There was a significant interaction
effect, where participants were less willing to take risk for every unit
increase where they hypothetically achieve their ideal weight when
taking into account their weight loss self-efficacy (β = −1.32, P = .05).
Model 2 was expanded to include individuals with a BMI of
30 and above. The results indicate that participants were more likely
to take more risk for every unit increase where they hypothetically
achieve their ideal weight (β = 11.2, P < .001) but less so under the
highest risk condition of death (β = −5.80, P = .04). The interactions
show a parallel trend where, compared to a low risk of chronic diar-
rhoea, participants were less likely to take the higher risk of death,
even if they would achieve ideal weight (β = −8.30, P = .03), control-
ling for all other variables in the model. On its own, weight loss self-
efficacy was not significantly predictive of risk willingness. Yet, the
three-way interaction in Model 2 demonstrated that participants were
more willing to take risks under ideal weight loss conditions even with
the risk of death, particularly when considering weight loss self-
TABLE 3 Predicting risk willingness using a self-efficacy scorea
Model 1 Model 2
n = 135 (P < .001) n = 223 (P < .001)
BMI 40+ or BMI 30+ with comorbidity BMI 30+
Beta coefficient (confidence interval) Beta coefficient (confidence interval)
Body mass index (BMI) 0.40 (−0.18 to 0.97) 0.50* (0.08-0.92)
Main effects
Condition
10% weight loss scenario Ref. Ref.
Ideal weight loss scenario 11.5** (4.29-18.76) 11.2*** (5.78-16.53)
Risk level
Low—chronic diarrhoea Ref. Ref.
Moderate—severe infection −4.92 (−12.22 to 2.40) −4.57 (−9.98 to 0.84)
High—death −3.37 (−10.64 to 3.91) −5.80* (−11.20 to −0.41)
Weight loss self-efficacy score 0.21 (−1.00 to 1.43) 0.54 (−0.38 to 1.47)
Interaction effects
Condition × risk level
Ideal weight loss × chronic diarrhoea Ref. Ref.
Ideal weight loss × severe infection −2.51 (−12.80 to 7.80) −2.31 (−9.95 to 5.33)
Ideal weight loss × death −8.49 (−18.74 to 1.77) −8.31* (−15.92 to −0.69)
Condition × self-efficacy score
10% weight loss Ref. Ref.
Ideal weight loss −1.32* (−2.45 to −0.19) −1.30** (−2.13 to −0.48)
Risk level × self-efficacy score
Low—chronic diarrhoea Ref. Ref.
Moderate—severe infection −0.60 (−1.74 to 0.53) −0.50 (−1.32 to 0.33)
High—death −0.91 (−2.05 to 0.23) −0.36 (−1.18 to 0.47)
Condition × risk level × self-efficacy score
Ideal weight loss × chronic diarrhoea Ref. Ref.
Ideal weight loss × severe infection 0.70 (−0.91 to 2.30) 0.71 (−0.46 to 1.90)
Ideal weight loss × death 1.22 (−0.39 to 2.83) 1.20* (0.03 to 2.36)
Abbreviation: BMI, body mass index.
aModels control for age, education, gender and race/ethnicity.
*P < .05.; **P < .01.; ***P < .001.
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efficacy (β = 1.20, P = .05). No demographic covariates were statisti-
cally significant in either model. A modest increase in BMI was signifi-
cantly related to risk willingness in Model 2 (β = 0.50, P = .02).
In order to further assess the impact of weight loss self-efficacy
within the interactions, follow-up margin predictions were conducted.
Figure 1 shows two margin predictions using the dichotomized (high
and low) weight loss self-efficacy variable for Model 1. Figure 2 shows
two margin predictions for Model 2. The projections demonstrate that
individuals in the sample who had lower weight loss self-efficacy were
more likely to take risk overall. This trend is significant for those with
a BMI of 30 and above in scenarios presenting one's ideal weight as
the outcome of bariatric surgery.
4 | DISCUSSION
The results indicate that weight loss self-efficacy is a predictor of par-
ticipants' willingness to take high risk for bariatric surgery in the con-
text of achieving one's ideal weight for those in the sample with
elevated BMIs. In the sample, individuals who had lower weight loss
self-efficacy were more likely to take a hypothetical risk of death
compared to a risk of chronic diarrhoea from surgery. Results were
significant for those individuals with a BMI of 30 and above in scenar-
ios presenting one's ideal weight as the outcome of bariatric surgery.
This trend was not significant for those scenarios in which there was
moderate risk compared to low risk across all scenarios.
There are important considerations from this study. In clinical
practice, adding a measure of weight loss self-efficacy within patient
assessments could identify those eligible patients who are most likely
to adopt bariatric surgery. In addition, a focus on shared decision-
making could optimize appropriate interventions while bolstering
patients' weight loss self-efficacy, particularly in relation to post-
surgical success as well.26-28
This study suggests that weight loss self-efficacy is an important
predictor for risk perceptions of bariatric surgery outcomes. It is also
important to consider if the severity of obesity itself was a factor in
participants' calculation of their willingness to take risk.11,12,29,30
There are also implications for individuals with low weight loss self-
F IGURE 1 Model 1 margin predictions for risk willingness. Light grey = 10% weight loss. Dark grey = ideal weight loss
F IGURE 2 Model 2 margin predictions for risk willingness. Light grey = 10% weight loss. Dark grey = ideal weight loss
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efficacy. Addressing this by way of providing time and/or tools for
increased problem- or emotion-focused coping in tandem with candi-
dacy consultations may enhance quality of life and post-surgical out-
comes (eg, reducing relapse rates). Integration of health
communication principles31 for bariatric surgery candidate materials
should be strategically tested and applied when aiming to increase risk
perceptions or intervene with this target population.32-35
This study's contribution should be considered within its limita-
tions. This study included a sample assessing perceptions at one time
point. This excluded other factors (eg, comprehensive health history,
insurance) that could contribute to treatment decision-making. Bariat-
ric surgery was the only intervention considered for this analysis. In
addition, the study compared acute and chronic risks together in anal-
ysis, where chronic diarrhoea could also be categorized as a moderate
risk provided quality-of-life concerns.36 Hypothetical thinking can be
a challenging task, and individuals with low numeracy or low literacy
abilities may have had challenges when presented with numerical risk
questions. There could have been additional items in the survey ques-
tionnaire about comorbidities (eg, heart disease).37 Finally, each par-
ticipant has his or her own ideal weight that may be different from
each other, although the statistical analysis aimed to control for this
concern.
The current study complements and adds to the literature on risk
perceptions for bariatric surgery as a weight loss intervention for eligi-
ble individuals with obesity. A strength of this study is that it is
grounded in theoretical concepts for individual decision-making. Addi-
tional empirical evidence is warranted to further understand specific
clinical decision-making within subpopulations. Future research can
directly apply and test theories with weight loss self-efficacy con-
structs to address patient expectations in clinical weight loss and
shared decision-making interventions. Although patients with obesity
generally prefer large weight reductions, addressing and identifying
levels of weight loss self-efficacy among eligible patients could
increase the uptake of bariatric surgery and enhance patient
outcomes.
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